Sabra Healthcare REIT, Inc. $SBRA Stock Position Lowered by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp decreased its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 3.5% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 283,588 shares of the real estate investment trust’s stock after selling 10,136 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in Sabra Healthcare REIT were worth $5,229,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. State of Michigan Retirement System lifted its holdings in shares of Sabra Healthcare REIT by 1.1% in the second quarter. State of Michigan Retirement System now owns 57,249 shares of the real estate investment trust’s stock valued at $1,056,000 after purchasing an additional 600 shares in the last quarter. Diversify Advisory Services LLC raised its position in Sabra Healthcare REIT by 5.7% during the first quarter. Diversify Advisory Services LLC now owns 12,878 shares of the real estate investment trust’s stock valued at $226,000 after buying an additional 689 shares during the period. IFP Advisors Inc lifted its stake in Sabra Healthcare REIT by 16.2% in the 1st quarter. IFP Advisors Inc now owns 5,060 shares of the real estate investment trust’s stock worth $88,000 after acquiring an additional 706 shares in the last quarter. Cherry Creek Investment Advisors Inc. boosted its position in Sabra Healthcare REIT by 4.4% during the 2nd quarter. Cherry Creek Investment Advisors Inc. now owns 19,074 shares of the real estate investment trust’s stock worth $352,000 after acquiring an additional 802 shares during the period. Finally, Ethos Financial Group LLC grew its stake in Sabra Healthcare REIT by 1.3% during the 2nd quarter. Ethos Financial Group LLC now owns 66,658 shares of the real estate investment trust’s stock valued at $1,229,000 after acquiring an additional 835 shares in the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Price Performance

NASDAQ SBRA opened at $18.59 on Tuesday. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The stock has a market capitalization of $4.64 billion, a PE ratio of 24.46, a price-to-earnings-growth ratio of 1.10 and a beta of 0.84. Sabra Healthcare REIT, Inc. has a 12-month low of $15.60 and a 12-month high of $19.97. The company has a 50 day moving average price of $18.37 and a two-hundred day moving average price of $18.32.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. The business had revenue of $190.04 million for the quarter, compared to the consensus estimate of $193.44 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. Sabra Healthcare REIT’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. As a group, equities analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 28th. Stockholders of record on Monday, November 17th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.5%. The ex-dividend date is Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio is 166.67%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on SBRA. Cantor Fitzgerald started coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price target for the company. Wall Street Zen downgraded shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. JMP Securities lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research note on Wednesday, August 6th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, October 8th. Finally, Truist Financial increased their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a report on Tuesday, September 2nd. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, Sabra Healthcare REIT has an average rating of “Moderate Buy” and an average target price of $20.75.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.